Endo dismisses lawsuit against the FDA after two-year battle By: Philadelphia Business Journal via Business Journals September 30, 2019 at 11:50 AM EDT The two-year court battle centered on the bulk compounding of the active ingredient in Endo's blood pressure medicine. Read More >>
